Clorazepate Dipotassium
Product Images NDC 67046-907

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Clorazepate Dipotassium (NDC 67046-907). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Contract Pharmacy Services-pa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30's Bottle Label (Clorazep2)

This is a medication package of Clorazepate tablets, with each tablet containing 7.5mg of Clorazepate dipotassium. It is a controlled substance and the usual dosage is mentioned as one tablet per day. The package contains 30 tablets and prescribing information is included in the package insert. The medication should be stored at a temperature between 20-25°C (68-77°F). The manufacturer is listed as Ranbaxy and the package was prepared by Contract Pharmacy Services in Pennsylvania. The expiration date mentioned on the package is 09/30/13.*

FDA Label Image

30's Bottle Label (Clorazep3)

CLORAZEPATE is a controlled substance that comes in a pill form of 15 mg tablets, with a package insert for full prescribing information. Each tablet contains 15 mg clorazepate dipotassium. The lot number for the pills is 2366284, and the pills are identified as RX 554 Eascg. They expire on 12/31/13. These pills should be stored at room temperature between 20-25°C (68-77°F) according to USP guidelines. The pills are packaged by Contract Pharmacy Services-PA and have an NDC number of 67046-907-30. If you have any doubts or questions, please refer to the package insert for more information.*

FDA Label Image

Structural Formula (Strucutre)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.